240 related articles for article (PubMed ID: 27198806)
1. Central Line Associated Blood Stream Infections in Pediatric Hematology/Oncology Patients With Different Types of Central Lines.
Hord JD; Lawlor J; Werner E; Billett AL; Bundy DG; Winkle C; Gaur AH;
Pediatr Blood Cancer; 2016 Sep; 63(9):1603-7. PubMed ID: 27198806
[TBL] [Abstract][Full Text] [Related]
2. Line days as a determinant of central line-associated bloodstream infections in pediatric patients with tunneled femoral peripherally inserted central catheters.
Koo KSH; Cooper AB; Monroe EJ; Reis J; Shivaram GM; Zerr DM
Pediatr Radiol; 2021 Jul; 51(8):1481-1486. PubMed ID: 33675377
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors.
Rinke ML; Milstone AM; Chen AR; Mirski K; Bundy DG; Colantuoni E; Pehar M; Herpst C; Miller MR
Pediatr Blood Cancer; 2013 Nov; 60(11):1882-9. PubMed ID: 23881643
[TBL] [Abstract][Full Text] [Related]
4. A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients.
Gaur AH; Bundy DG; Werner EJ; Hord JD; Miller MR; Tang L; Lawlor JP; Billett AL;
Infect Control Hosp Epidemiol; 2017 Jun; 38(6):690-696. PubMed ID: 28399945
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Ambulatory Central Line-Associated Bloodstream Infections.
Rinke ML; Heo M; Saiman L; Bundy DG; Rosenberg RE; DeLaMora P; Rabin B; Zachariah P; Mirhaji P; Ford WJH; Obaro-Best O; Drasher M; Klein E; Peshansky A; Oyeku SO
Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33386333
[TBL] [Abstract][Full Text] [Related]
6. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
[TBL] [Abstract][Full Text] [Related]
8. A Model to Predict Central-Line-Associated Bloodstream Infection Among Patients With Peripherally Inserted Central Catheters: The MPC Score.
Herc E; Patel P; Washer LL; Conlon A; Flanders SA; Chopra V
Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1155-1166. PubMed ID: 28807074
[TBL] [Abstract][Full Text] [Related]
9. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results.
Bundy DG; Gaur AH; Billett AL; He B; Colantuoni EA; Miller MR;
Pediatrics; 2014 Dec; 134(6):e1678-85. PubMed ID: 25404721
[TBL] [Abstract][Full Text] [Related]
10. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
[TBL] [Abstract][Full Text] [Related]
11. Central Line-Associated Bloodstream Infections in Children With Hematologic and Oncologic Diseases: First Prevalence Results From a University Hospital.
Özalp Gerçeker G; Yardımcı F; Aydınok Y
J Pediatr Oncol Nurs; 2019; 36(5):327-336. PubMed ID: 31027430
[TBL] [Abstract][Full Text] [Related]
12. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
[TBL] [Abstract][Full Text] [Related]
13. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
[TBL] [Abstract][Full Text] [Related]
14. Low Risk of Central Line-associated Bloodstream Infections in Pediatric Hematology/Oncology Patients.
Kristinsdottir I; Haraldsson A; Gudlaugsson O; Thors V
Pediatr Infect Dis J; 2021 Sep; 40(9):827-831. PubMed ID: 33990520
[TBL] [Abstract][Full Text] [Related]
15. Impact of postplacement adjustment of peripherally inserted central catheters on the risk of bloodstream infection and venous thrombus formation.
Baxi SM; Shuman EK; Scipione CA; Chen B; Sharma A; Rasanathan JJ; Chenoweth CE
Infect Control Hosp Epidemiol; 2013 Aug; 34(8):785-92. PubMed ID: 23838218
[TBL] [Abstract][Full Text] [Related]
16. Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
Chong CY; Ong RY; Seah VX; Tan NW; Chan MY; Soh SY; Ong C; Lim AS; Thoon KC
J Paediatr Child Health; 2020 Jan; 56(1):123-129. PubMed ID: 31145505
[TBL] [Abstract][Full Text] [Related]
17. Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit.
Advani S; Reich NG; Sengupta A; Gosey L; Milstone AM
Clin Infect Dis; 2011 May; 52(9):1108-1115. PubMed ID: 21454298
[TBL] [Abstract][Full Text] [Related]
18. Peripherally inserted central catheter-associated bloodstream infection: Risk factors and the role of antibiotic-impregnated catheters for prevention.
Kagan E; Salgado CD; Banks AL; Marculescu CE; Cantey JR
Am J Infect Control; 2019 Feb; 47(2):191-195. PubMed ID: 30180989
[TBL] [Abstract][Full Text] [Related]
19. Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.
Kelada AS; Foster TB; Gagliano GC; Worley S; Tang A; Arakoni VA; Foster CB
Infect Control Hosp Epidemiol; 2023 Mar; 44(3):377-383. PubMed ID: 35475427
[TBL] [Abstract][Full Text] [Related]
20. Reduction of central line-associated bloodstream infections in a pediatric hematology/oncology population.
Wilson MZ; Deeter D; Rafferty C; Comito MM; Hollenbeak CS
Am J Med Qual; 2014; 29(6):484-90. PubMed ID: 24226650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
